Article

AJMC® in the Press, November 5, 2021

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A blog post by PhRMA referenced a study published in the October 2021 issue of The American Journal of Managed Care® (AJMC®). The study, “340B Drug Pricing Program and Hospital Provision of Uncompensated Care,” found that participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care.

A piece by Oil City News cited an article published on AJMC.com, the website of AJMC®. The article, “A Timeline of COVID-19 Developments in 2020,” reviewed how the pandemic evolved and progressed through 2020, which closed with the arrival of vaccines but also continued challenges.

Related Videos
Jaime Almandoz, MD, MBA
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Leigh Maria Ramos-Platt, MD
Molly Dean, MSW, Siftwell
Tiffany Meng, PharmD, oncology pharmacist with UCSF Health
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo